Neuroscan
NeuroScan is a privately owned specialist mental health care (GGZ) practice in Dordrecht, Netherlands, delivering psychodiagnostics, psychotherapy, pharmacotherapy, and home-based treatment to children, adolescents, and adults, reimbursed through Dutch health insurers and 10 Zuid-Holland Zuid municipalities.
- Company typePrivate
- Founded2009
- HeadquartersDordrecht, Netherlands
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Neuroscan does
NeuroScan is a specialist mental health care (GGZ) practice headquartered at Singel 123, 3311 PC Dordrecht, Netherlands, founded in 2009 and privately operated under KVK registration 24467515. The practice delivers diagnostic and therapeutic services to children, adolescents, and (young) adults with psychiatric vulnerabilities including ADHD, autism, anxiety, mood disorders, trauma and PTSD, personality disorders, psychosis, and systemic family problems. Service modalities include psychodiagnostic assessment, psychotherapy (CBT, EMDR, NET, schema therapy, ACT, systemic therapy, emotion regulation), pharmacotherapy, parent guidance, group therapy, and home-based treatment, with a blended-care extension via the third-party Therapieland e-health platform. The clinical team comprises roughly 30+ multidisciplinary staff including child and youth psychiatrists, GZ-psychologists, psychotherapists, system therapists, orthopedagogues, and psychiatric nurses, led by bestuurders Monica Verlinde and Annerieke Luijendijk with Sander Donkers as Directeur bedrijfsvoering.
The business model is fully reimbursed rather than consumer-paid: adults (18+) are covered by contracted Dutch health insurers (VGZ, Achmea/ZK, ASR, DSW, ONVZ/Caresq, CZ, Zorg en Zekerheid) under the NZA Zorgprestatiemodel with patients paying only the mandatory €385 deductible, while youth under 18 are fully funded by municipalities under the woonplaatsbeginsel, with NeuroScan contracted by 10 municipalities in Zuid-Holland Zuid. All patients require GP or municipal youth-team referrals; there is no self-referral pathway. The practice holds HKZ certification (ISO-9001 aligned) and an NZA-approved kwaliteitsstatuut, with documented GDPR/AVG compliance.
Operationally, NeuroScan runs from a single physical location in Dordrecht supplemented by home visits and digital sessions, with current adult waiting times of 16–26 weeks depending on insurer (Menzis at intake stop) and youth waiting times of 16 weeks from referral to intake and a further 17 weeks to treatment start. The firm shows no external investment, parent company, or acquisition activity, consistent with a founder/management-owned independent practice.
Neuroscan firmographics
Firmographics- Name
- Neuroscan
- Legal name
- NeuroScan
- Website
- https://neuroscan.nl
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- NeuroScan is a privately owned specialist mental health care (GGZ) practice in Dordrecht, Netherlands, delivering psychodiagnostics, psychotherapy, pharmacotherapy, and home-based treatment to children, adolescents, and adults, reimbursed through Dutch health insurers and 10 Zuid-Holland Zuid municipalities.
- Ownership category
- akta.pro rank
Where Neuroscan is headquartered
LocationHeadquarters
- HQ city
- Dordrecht
- HQ country
- Netherlands
- HQ region
- Europe
Offices1 record
Markets served
Neuroscan business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Others, Technology or R&D, Marketing or Sales
Revenue model
- Health Insurance Reimbursement (Adults 18+): NeuroScan has contracts with major Dutch health insurers (VGZ, Achmea/ZK, ASR, DSW, ONVZ/Caresq, CZ, Zorg en Zekerheid). Insured adults pay the mandatory deductible (€385) and the insurer covers treatment costs. Patients without contracted insurers receive monthly invoices to submit to their insurer. Billing follows the NZA Zorgprestatiemodel (care performance model) introduced in 2022, based on a 'planning is realisatie' (planned equals realized) principle.
- Municipal Youth Care Funding (Under 18): For patients under 18, diagnostics and treatment are fully covered by the municipality under the 'woonplaatsbeginsel' (residence principle). NeuroScan is a contracted care provider for 10 municipalities in Zuid-Holland Zuid: Alblasserdam, Dordrecht, Gorinchem, Hardinxveld-Giessendam, Hendrik-Ido-Ambacht, Hoeksche Waard, Molenlanden, Papendrecht, Sliedrecht, and Zwijndrecht.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Adults (18+) — Insurance-covered treatment |
| Subscription | Annual | Youth under 18 — Municipal funding |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Neuroscan product offering
Product offeringCore offering
NeuroScan is a specialist mental health care (GGZ) practice in Dordrecht, Netherlands delivering psychodiagnostic assessments and treatment services (psychotherapy, pharmacotherapy, parent guidance, group therapy, home treatment, and blended care) to children, adolescents, and (young) adults with psychiatric vulnerabilities. A multidisciplinary team of psychiatrists, GZ-psychologists, psychotherapists, system therapists, psychiatric nurses, and orthopedagogues provides integrated care from a single team.
Product overview
NeuroScan is a specialist mental health care (GGZ) practice offering a coordinated portfolio of diagnostic and treatment services for children, adolescents, and (young) adults. The core offering consists of psychodiagnostic assessment services (including family, intelligence, neuropsychological, and personality testing) and a range of treatment modalities: psychotherapy (covering CBT, EMDR, schema therapy, ACT, systemic therapy, NET, and emotion regulation), pharmacotherapy, parent guidance, group therapy, and home-based treatment. All services are delivered through a multidisciplinary team (psychologists, psychiatrists, system therapists, nurses) operating from a single location in Dordrecht. The practice also offers blended-care combining face-to-face treatment with an E-health platform (Therapieland). Referrals come via general practitioners for adults (18+) and municipalities under the youth care system for those under 18.
Differentiator
Problem solved
Functional benefit
Products and services
- Psychodiagnostisch onderzoek (Psychodiagnostic Assessment) Comprehensive suite of psychological diagnostic assessments covering family diagnostics, intelligence testing, neuropsychological evaluation, social-emotional development assessment, child psychiatric evaluation, psychiatric evaluation for adults, personality assessment, and developmental anamnesis, used to map the causes of mental health concerns from a broad perspective before establishing a care plan.
- Psychotherapie (Psychotherapy) Psychotherapeutic treatments including cognitive behavioral therapy (CGT/CBT), trauma treatments (EMDR, NET, imaginary exposure and rescripting), Acceptance and Commitment Therapy (ACT), schema therapy, systemic therapy, and emotion regulation therapy, delivered as individual and/or family-focused treatment trajectories.
- Farmacotherapie (Pharmacotherapy) Medication-based treatment of psychiatric complaints delivered by a psychiatrist who advises on the pros and cons of medication, explains mechanisms of action, risks, and side effects, and monitors dosage in collaboration with the GP.
- Ouderbegeleiding (Parent Guidance) Support program for parents of children with psychological complaints, guiding parents through the child's developmental problems, helping adapt parenting to the child's needs, and including practical elements such as setting household rules and sleep rituals, delivered at the practice or at home.
- Groepstherapie (Group Therapy) Various group treatment programs that create a place for meeting, learning from each other, and exchanging experiences, designed to normalize psychological vulnerability through shared conversation and recovery-oriented group support.
- Thuisbehandeling (Home Treatment) Tailored treatment trajectories delivered in the patient's own environment when the step to the practice is too large or treatment would be more effective at home, applied for school refusal, severe anxiety and OCD, depression preventing leaving the house, or families with newborn children where parents experience psychological problems.
Quantifiable outcome
- Children/youth: 16 weeks from referral to intake, 4 weeks from intake to assessment, 17 weeks from intake to treatment.
- +1 more outcomes
Companies that use Neuroscan
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
Neuroscan technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Neuroscan partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- Dutch Health Insurers (VGZ, Achmea/ZK, ASR, DSW, ONVZ/Caresq, CZ, Zorg en Zekerheid)coreNeuroScan has active contracts for 2026 with major Dutch health insurers for adult GGZ care. These insurers cover treatment costs for insured patients, with patients paying only the mandatory deductible. Menzis currently has an intake stop.
- 10 Municipalities in Zuid-Holland Zuid (Alblasserdam, Dordrecht, Gorinchem, Hardinxveld-Giessendam, Hendrik-Ido-Ambacht, Hoeksche Waard, Molenlanden, Papendrecht, Sliedrecht, Zwijndrecht)coreNeuroScan is a contracted care provider for youth care under the woonplaatsbeginsel (residence principle) for 10 municipalities in Zuid-Holland Zuid, providing fully municipally-funded diagnostic and treatment services for children and adolescents under 18.
- Klachtenportaal Zorg (Complaints Portal Healthcare)minorNeuroScan is affiliated with Klachtenportaal Zorg, an external complaints resolution organization that provides independent support for patients who cannot or prefer not to discuss complaints directly with the practice, handling complaint intake and procedure selection.
- Jeugdstem (Youth Voice)minorUnder the Dutch Youth Act (Jeugdwet), NeuroScan provides access to a free, independent confidential advisor (vertrouwenspersoon) through Jeugdstem for youth receiving care, offering support with questions, complaints, or concerns about the care provided.
Scale indicators2 records
Recent moves6 records
Expansion highlights5 records
Neuroscan competitors and assessment
Company assessmentOthers
- Therapieland: Therapieland is a leading Dutch e-health platform used by GGZ practices to deliver blended care, including the digital modules and video tools NeuroScan integrates. Comparable only as a technology/enablement partner rather than a competitor, but relevant as the infrastructure underlying NeuroScan's blended-care offering.
- Reinier van Arkel: Reinier van Arkel is a Dutch specialist GGZ provider serving the 's-Hertogenbosch region offering diagnostic and treatment services for severe and complex psychiatric conditions. Comparable multidisciplinary service model to NeuroScan but at regional institutional scale rather than single-practice scale.
Emerging players
- OpenUp: OpenUp is a Dutch-founded digital mental health platform providing online therapy and coaching sessions, often via employer benefits. Competes with NeuroScan for the mild-to-moderate adult mental health segment with a fully digital, self-referral-enabled model.
- Mindler: Mindler is a digital mental health provider operating in the Netherlands offering online psychological treatment with self-referral. Targets the same patient population as NeuroScan's adult anxiety/depression services but competes on access speed rather than clinical depth.
- iPractice: iPractice is a Dutch online GGZ practice offering psychology and psychiatry treatment via video and chat, accepting self-referrals. Competes with NeuroScan for adult GGZ demand but bypasses the GP-referral requirement, representing the digital-first threat to traditional referral-led practices.
Broad incumbents
- Lentis: Lentis is a Dutch specialist GGZ provider serving the provinces of Groningen, Drenthe, and Overijssel with inpatient and outpatient psychiatry. Comparable clinical modalities (psychotherapy, pharmacotherapy, diagnostics) to NeuroScan at regional multi-site scale.
- PsyQ: PsyQ is the outpatient specialist GGZ arm of Parnassia Groep, operating numerous locations across the Netherlands delivering psychotherapy, pharmacotherapy, and diagnostics for anxiety, depression, ADHD, and personality disorders. Directly comparable service portfolio to NeuroScan, but at significantly larger scale and broader geographic footprint.
- Parnassia Groep: Parnassia Groep is the largest Dutch mental health and addiction care provider, operating multiple brands including PsyQ across the Netherlands. Represents the dominant incumbent consolidator in the Dutch GGZ market and the most likely strategic acquirer profile for a practice like NeuroScan.
- GGZ inGeest: GGZ inGeest is a major Dutch specialist GGZ provider (part of Amsterdam UMC / GGZ Noord-Holland-Noord) offering diagnostic and treatment services for mood, anxiety, psychotic, and personality disorders. Comparable clinical scope to NeuroScan at significantly larger institutional scale.
- Dimence: Dimence is a Dutch specialist GGZ provider operating across Overijssel and surrounding regions, offering diagnostics, psychotherapy, and pharmacotherapy for adults and youth. Comparable multidisciplinary GGZ service mix to NeuroScan at significantly larger organizational scale.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights5 records
Customer concentration
Neuroscan social profiles
Digital presenceNeuroscan compliance and trust
Trust signalCompliance2 records
Neuroscan financial estimates
Financial estimateRevenue estimate
Valuation estimate
Neuroscan leadership team
Management profileNumber of profiles
Profiles3 records
Neuroscan funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Neuroscan M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Neuroscan
What does Neuroscan do?
NeuroScan is a specialist mental health care (GGZ) practice in Dordrecht, Netherlands delivering psychodiagnostic assessments and treatment services (psychotherapy, pharmacotherapy, parent guidance, group therapy, home treatment, and blended care) to children, adolescents, and (young) adults with psychiatric vulnerabilities. A multidisciplinary team of psychiatrists, GZ-psychologists, psychotherapists, system therapists, psychiatric nurses, and orthopedagogues provides integrated care from a single team.
Is Neuroscan a public or private company?
Neuroscan is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Neuroscan founded?
Neuroscan was founded in 2009. It employs 11 to 50 people.
Where is Neuroscan based?
Neuroscan is headquartered in Dordrecht, Netherlands, in the Europe region.
How does Neuroscan make money?
Two revenue lines are on record. Health Insurance Reimbursement (Adults 18+) is the primary driver. The others are municipal Youth Care Funding (Under 18).
Who are Neuroscan's main competitors?
Others on record are Therapieland and Reinier van Arkel. Emerging players are OpenUp, Mindler and iPractice. Broad incumbents are Lentis, PsyQ, Parnassia Groep, GGZ inGeest and Dimence.
Does Neuroscan have an API?
No public API is recorded for Neuroscan.